Min Wu
About Min Wu
Min Wu is the VP of Biology, known for her extensive background in biomedical sciences and leadership in therapeutic development for genetic diseases.
Current Title and Responsibilities
Min Wu currently holds the position of Vice President (VP), Biology. In this role, Min oversees various biological research projects and teams, bringing extensive expertise in discovery biology, pharmacology, biomarker development, and translational research to the organization.
Education and Postdoctoral Training
Min Wu earned a Ph.D. in Biomedical Sciences from the Oak Ridge National Laboratory/University of Tennessee. Following the doctoral degree, Min completed postdoctoral training at the prestigious Whitehead Institute of the Massachusetts Institute of Technology (MIT). These institutions provided a strong foundation in biomedical research and scientific methodologies.
Professional Background and Former Roles
Min Wu has held various influential positions in renowned biotechnology organizations. Prior to the current role, Min served as Senior Director of Biology at Proteostasis Therapeutics. Additionally, Min has accumulated significant experience at FORMA Therapeutics, Agios Pharmaceuticals, and AVEO Oncology, handling important responsibilities in discovery biology, pharmacology, biomarker development, and translational research.
Collaboration with Astellas Pharma
During the tenure at Proteostasis Therapeutics, Min Wu led a significant multi-year collaboration program with Astellas Pharma. The focus of this collaboration was on the discovery and early development of a small molecule therapeutic targeting a rare genetic liver disease. Min's leadership played a crucial role in advancing this collaborative research effort.
Research on Small Molecule Programs
Min Wu has overseen multiple small molecule programs aimed at addressing genetic diseases causing the dysregulation of the proteostasis network. These programs have been essential in advancing the understanding and treatment of genetic conditions by targeting specific molecular pathways involved in disease processes.